Clinical Trials in Los Angeles

Showing 2641-2660 of 8,046 trials

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

NCT04160065

In this clinical phase I, non-randomized, open-label, uncontrolled, interventional, multi-center trial, 20 adult subjects (≥ 18 years of age) with advanced non-melanoma skin cancers will receive a fixed dose of 0.1 mg of IFx-Hu2.0 intralesionally as monotherapy in up to three lesions at up to three time points. Subjects will be observed for any acute adverse events (AEs) post injection and for any delayed AEs at Day 28, 35 and/or 42 ± 7 days, depending on the cohort (exposure escalation and expansion design).

Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaNon-Melanoma Skin Cancers

TuHURA Biosciences, Inc.23 participantsStarted Mar 2020

Los Angeles, California, United States • Tampa, Florida, United States • Boston, Massachusetts, United States +1 more locations

COMPLETEDNA< 1 mile

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

NCT04851691

The goal of this study will be to design, implement and test the impact of a quality improvement (QI) intervention that uses an EHR CDS tool among physicians newly ordering an antipsychotic medication for older adults with ADRD. The study team hypothesizes that the intervention will reduce each participating clinician's pill days per patient prescribed.

Alzheimer DiseaseDementia AlzheimersDementia of Alzheimer Type

University of California, Los Angeles158 participantsStarted Aug 2021

Los Angeles, California, United States

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions

Find Trials by Condition in Los Angeles

Suture Versus Staples for Wound Closure in Orthopaedic Trauma Surgery

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects

Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors

The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 3)

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A

A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Breast Cancer Index (BCI) Registry

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

2021 PMT iAge® Intervention Trial by Edifice Health

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities